Brief, factual summary in Slovak: The article focuses on the development of the opioid crisis and new weight loss drugs expected this year. Researchers are looking for new data to explain the decline in U.S. drug overdose deaths. A new weight loss drug is expected to be approved this year. Skilled nursing facility capacity in the US has fallen by 5% since the COVID-19 pandemic. High-dose flu vaccine benefits older adults with diabetes. Bariatric surgery and GLP-1 drugs promote sustained fat loss. Light activity reduces the risk of death in CKM syndrome. FDA requests removal of suicidal ideation warning from GLP-1 RA drugs.